Compounds > camptothecin
Page last updated: 2024-08-22

camptothecin and Tumor Lysis Syndrome

camptothecin has been researched along with Tumor Lysis Syndrome in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atasoy, A; Babacan, NA; Cihan, S; Kos, TF; Yildirim, Y1
Hashiguchi, K; Kuramoto, T; Matsuyama, S; Tanaka, R1
Hentrich, M; Hoffmann, U; Lutz, L; Reitmeier, M; Scheidt, B; Schiel, X1
Boisseau, M; Bugat, R; Mahjoubi, M1
Crawford, J; Garst, J; Persons, DA; Vollmer, R1
Inai, K; Kishi, S; Morinaga, K; Naiki, H; Tsutani, H; Ueda, T1

Other Studies

6 other study(ies) available for camptothecin and Tumor Lysis Syndrome

ArticleYear
Hypersensitivity and tumor lysis syndrome associated with cetuximab treatment: should we be afraid?
    Tumori, 2015, Apr-28, Volume: 101, Issue:2

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Neoplasms; Camptothecin; Cetuximab; Colorectal Neoplasms; Drug Hypersensitivity; Emergency Treatment; Humans; Irinotecan; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Tumor Lysis Syndrome

2015
[Tumor lysis syndrome after FOLFIRI+cetuximab for ascending colon cancer].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2015, Volume: 112, Issue:4

    Topics: Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Colon, Ascending; Colonic Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Tumor Lysis Syndrome

2015
Fatal tumor lysis syndrome after irinotecan/5-FU/folinic acid/bevacizumab-containing therapy in a patient heavily pretreated for metastatic colon cancer.
    Acta oncologica (Stockholm, Sweden), 2008, Volume: 47, Issue:1

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Fatal Outcome; Fluorouracil; Humans; Irinotecan; Leucovorin; Lung Neoplasms; Male; Middle Aged; Tumor Lysis Syndrome

2008
Rapid tumour lysis syndrome in a metastatic colorectal cancer increased by treatment (CPT-11)
    European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:4

    Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Phytogenic; Camptothecin; Colonic Neoplasms; Fatal Outcome; Female; Humans; Irinotecan; Tumor Lysis Syndrome

1996
Tumor lysis syndrome and acute renal failure after treatment of non-small-cell lung carcinoma with combination irinotecan and cisplatin.
    American journal of clinical oncology, 1998, Volume: 21, Issue:4

    Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Irinotecan; Lung Neoplasms; Tumor Lysis Syndrome

1998
Hepatic tumor rupture following effectual treatment with irinotecan in a patient with highly refractory malignant lymphoma.
    International journal of hematology, 1999, Volume: 70, Issue:3

    Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Fatal Outcome; Humans; Irinotecan; Liver; Liver Neoplasms; Lymphoma, B-Cell; Male; Middle Aged; Rupture; Tumor Lysis Syndrome

1999